Family Practice NewsNewest oral DMTs haven’t yet made a big impact in the MS worldJune 4, 2020Neurology
Family Practice NewsNo benefit of three commonly used medications for MS fatigueJune 1, 2020Neurology
Family Practice NewsNilotinib is safe in moderate and advanced Parkinson’s diseaseMay 29, 2020Neurology
Family Practice NewsMixed results for aducanumab in two phase 3 trials for Alzheimer’s diseaseMay 27, 2020Neurology
Family Practice NewsGalcanezumab looks promising for treatment-resistant migraineMay 27, 2020Neurology
Family Practice NewsCOVID-19: Psychiatrists assess geriatric harm from social distancingMay 27, 2020COVID-19 UpdatesMental HealthNeurologyGeriatrics
Family Practice NewsSocial isolation tied to higher risk of cardiovascular events, deathMay 27, 2020COVID-19 UpdatesNeurologyCardiology
Family Practice NewsAHA offers advice on prehospital acute stroke triage amid COVID-19May 21, 2020COVID-19 UpdatesNeurology
Family Practice NewsAAN publishes ethical guidance on patient care during the pandemicMay 20, 2020COVID-19 UpdatesBusiness of MedicineNeurology
Family Practice NewsBlood pressure lowering lessens risk of dementia, cognitive declineMay 19, 2020NeurologyCardiology
Family Practice NewsFrontal lobe glucose abnormalities may indicate increased SUDEP riskMay 18, 2020Neurology
